Integrated genomic and epigenomic analysis of breast cancer brain metastasis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Salhia, Bodour ^a   Kiefer, Jeff ^a   Ross, Julianna T D ^a   Metapally, Raghu ^a   Martinez, Rae Anne ^a   Johnson, Kyle N ^a   DiPerna, Danielle M ^a   Paquette, Kimberly M ^a   Jung, Sungwon ^a   Nasser, Sara ^a   Wallstrom, Garrick ^b   Tembe, Waibhav ^a   Baker, Angela ^a   Carpten, John ^a   Resau, Jim ^c   Ryken, Timothy ^d   Sibenaller, Zita ^e   Petricoin, Emanuel F ^f   Liotta, Lance A ^f   Ramanathan, Ramesh K ^g   Berens, Michael E ^a   Tran, Nhan L ^a   more..

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b Arizona State University   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d Iowa Spine and Brain Institute   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f GEORGE MASON UNIVERSITY   (United States)

^g Virginia G Piper Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ARTICLE; ATAD2 GENE; ATM GENE; AURKA GENE; AURKB GENE; BASAL LIKE BREAST CANCER; BRAF GENE; BRAIN METASTASIS; BREAST CANCER; CELL ADHESION; CELL CYCLE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 21P; CHROMOSOME 5P; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME DELETION; CHROMOSOME XQ; CONTROLLED STUDY; CRYAB GENE; DERL1 GENE; DNA METHYLATION; DNMTRB GENE; DOWN REGULATION; EDN3 GENE; EPIGENETICS; FOXM1 GENE; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENETIC GAIN; GENOME ANALYSIS; HSPB2 GENE; HUMAN; HUMAN TISSUE; ITGAM GENE; KRT8 GENE; NEK2A GENE; NUCLEOTIDE SEQUENCE; PENK GENE; UPREGULATION;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMOSOME ABERRATIONS; DATA MINING; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84900427972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085448     Document Type: Article

References (31)

1. Maher EA, Mietz J, Arteaga CL, DePinho RA, Mohla S (2009) Brain metastasis: opportunities in basic and translational research. Cancer Res 69: 6015-6020.
2. Tosoni A, Franceschi E, Brandes AA (2008) Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome? Crit Rev Oncol Hematol 68: 212-221.
3. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167: 913-920. (Pubitemid 41416243)
4. Gori S, Rimondini S, De Angelis V, Colozza M, Bisagni G, et al. (2007) Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. Oncologist 12: 766-773. (Pubitemid 47328220)
5. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, et al. (2010) Metastatic behavior of breast cancer subtypes. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28: 3271-3277.
6. Olshen AB, Venkatraman ES, Lucito R, Wigler M (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572. (Pubitemid 41180205)
7. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, et al. (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome biology 12: R41.
8. Merico D, Isserlin R, Bader GD (2011) Visualizing gene-set enrichment results using the Cytoscape plug-in enrichment map. Methods in molecular biology 781: 257-277.
9. Chen J, Bardes EE, Aronow BJ, Jegga AG (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic acids research 37: W305-311.
10. Wang C, Iakovlev VV, Wong V, Leung S, Warren K, et al. (2009) Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Genes, chromosomes & cancer 48: 1091-1101.
11. Nikolsky Y, Sviridov E, Yao J, Dosymbekov D, Ustyansky V, et al. (2008) Genome-wide functional synergy between amplified and mutated genes in human breast cancer. Cancer research 68: 9532-9540.
12. Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, et al. (2006) Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer research 66: 4065-4078.
13. El Gammal AT, Bruchmann M, Zustin J, Isbarn H, Hellwinkel OJ, et al. (2010) Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 56-64.
14. Raeder MB, Birkeland E, Trovik J, Krakstad C, Shehata S, et al. (2013) Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers. PLoS One 8: e54873.
15. Ciro M, Prosperini E, Quarto M, Grazini U, Walfridsson J, et al. (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer research 69: 8491-8498.
16. Wang J, Hua H, Ran Y, Zhang H, Liu W, et al. (2008) Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis. Breast cancer research: BCR 10: R7.
17. Wang S, Li W, Liu N, Zhang F, Liu H, et al. (2012) Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer. Journal of cellular biochemistry 113: 1904-1914.
18. Ishiwata T, Orosz A, Wang X, Mustafi SB, Pratt GW, et al. (2012) HSPB2 is dispensable for the cardiac hypertrophic response but reduces mitochondrial energetics following pressure overload in mice. PLoS One 7: e42118.
19. Benjamin IJ, Guo Y, Srinivasan S, Boudina S, Taylor RP, et al. (2007) CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice. American journal of physiology Heart and circulatory physiology 293: H3201-3209. (Pubitemid 350106548)
20. Baysal BE, Willett-Brozick JE, Taschner PE, Dauwerse JG, Devilee P, et al. (2001) A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region. European journal of human genetics: EJHG 9: 121-129. (Pubitemid 32156693)
21. Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, et al. (2013) Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Molecular cancer therapeutics 12: 104-116.
22. Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413.
23. (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
24. Hamilton A, Sibson NR (2013) Role of the systemic immune system in brain metastasis. Molecular and cellular neurosciences 53: 42-51.
25. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
26. Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS (2010) Clinical implementation of the intrinsic subtypes of breast cancer. The lancet oncology 11: 718-719; author reply 720-711.
27. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27: 1160-1167.
28. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, et al. (2008) Subtypes of breast cancer show preferential site of relapse. Cancer research 68: 3108-3114.
29. Shao MM, Liu J, Vong JS, Niu Y, Germin B, et al. (2011) A subset of breast cancer predisposes to brain metastasis. Medical molecular morphology 44: 15-20.
30. Harrell JC, Prat A, Parker JS, Fan C, He X, et al. (2012) Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast cancer research and treatment 132: 523-535.
31. Weigelt B, Hu Z, He X, Livasy C, Carey LA, et al. (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer research 65: 9155-9158. (Pubitemid 41507977)